We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 72

Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) 2015 FCA 634
  • King & Wood Mallesons
  • Australia
  • July 7 2015

Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice


Vision Eye Institute Ltd v Kitchen (no 2) 2015 QSC 66
  • King & Wood Mallesons
  • Australia
  • July 2 2015

In this case, the Queensland Supreme Court awarded a significant amount of damages for contingent loss of income flowing from a breach of contract


Privacy Commissioner’s decision set aside by the Federal Court
  • King & Wood Mallesons
  • Australia
  • March 16 2015

A recent decision by Federal Court of Australia illustrated two things about privacy complaints - or at least those that end up before the courts:


Experimental evidence comply with the rules or risk inadmissibility
  • King & Wood Mallesons
  • Australia
  • March 22 2013

By refusing to allow Generic Health to adduce experimental evidence in a patent case currently being heard in the Federal Court, Justice Jagot has


Just genes? Lessons from the Myriad litigation
  • King & Wood Mallesons
  • Australia
  • August 19 2013

Last month the United States Supreme Court ruled that certain naturally occurring DNA sequences (the BRCA1 and BRCA2 genes, mutations in which are


Australian case notes - Odisho v Bonazzi 2014 VSCA 11
  • King & Wood Mallesons
  • Australia
  • May 20 2014

In this case the appellant, a patient who suffered a thromboembolic event following the use of tranexamic acid, claimed that her doctor had


ACCC joins NRM to Advanced Medical Institute proceedings, alleging unfair contract terms
  • King & Wood Mallesons
  • Australia
  • November 3 2011

On 7 September 2011, the ACCC announced that the Federal Court had granted orders to add NRM Corporation Pty Ltd and NRM Trading Pty Ltd as respondents in the ACCC’s existing case against Advanced Medical Institute for alleged unconscionable conduct


FWC supports employer’s right to nominate doctor
  • King & Wood Mallesons
  • Australia
  • July 8 2014

The Fair Work Commission has ruled that an employer was entitled to require one of its employees to attend an appointment with a general practitioner


High Court grants special leave to appeal extension of time in pharmaceutical patent case
  • King & Wood Mallesons
  • Australia
  • April 15 2014

Last Friday the High Court of Australia granted Alphapharm special leave to appeal from a decision of the Full Federal Court in Aspen Pharma Pty Ltd


De-identification and medical records in NSW
  • King & Wood Mallesons
  • Australia
  • October 24 2014

Are health service providers in New South Wales obliged by the Health Records and Information Privacy Act 2002 (NSW) to de-identify medical records